지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2014.1
- 수록면
- 584 - 591 (8page)
이용수
초록· 키워드
오류제보하기
Purpose: The aim of this study was to evaluate and compare the long-term clinical outcomes of the spot drug-eluting stent (DES) implantation strategy, which is used to minimize implanted stent length and the number of stents, versus full lesion coveragefor treatment of coronary artery stenoses. Materials and Methods: We evaluated1-year clinical outcomes of 1619 patients with stent implantation for a single coronarylesion. They were divided into two groups: those treated by full lesion coverage (n=1200) and those treated with the spot stenting strategy (n=419). The combined occurrence of 1-year target vessel failure (TVF), including cardiac death, target-vessel related myocardial infarction, or ischemia-driven target-vessel revascularizationwas evaluated. Results: The spot DES implantation group had a shorter stent length (23.14±9.70 mm vs. 25.44±13.24 mm, respectively; p<0.001) and a fewer number of stents (1.09±0.30 vs. 1.16±0.41, respectively; p<0.001), even though the average lesion length was similar to the full lesion coverage group (21.36±10.30 mm vs. 20.58±10.97 mm, respectively; p=0.206). Spot DES implantationwas superior to full DES coverage with respect to 1-year TVF (1.4% vs. 3.3%, p=0.044). Cox proportional hazard model analysis showed that the risk for 1-year TVF was almost 60% lower among patients who received spot DESs compared to those who received full DES coverage after adjustment for other risk factors (HR=0.40, 95% confidence interval=0.17-0.98; p=0.046). Conclusion: Minimizing stent length and the number of stents with overlapping by spot DES implantation may result in reduced rates of 1-year TVF, compared with full DES coverage.
목차
등록된 정보가 없습니다.
참고문헌 (20)
참고문헌 신청
Abbott JD / 2007 / Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood In
Caputo RP / 2012 / Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry) / Am J Cardiol 110 : 350 ~ 355
Colombo A / 2001 / Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions / J Am
Costa JR Jr / 2010 / Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry
Cutlip DE / 2007 / Clinical end points in coronary stent trials: a case for standardized definitions / Circulation 115 : 2344 ~ 2351
Caputo RP / 2012 / Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry) / Am J Cardiol 110 : 350 ~ 355
Colombo A / 2001 / Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions / J Am
Costa JR Jr / 2010 / Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry
Cutlip DE / 2007 / Clinical end points in coronary stent trials: a case for standardized definitions / Circulation 115 : 2344 ~ 2351
이 논문의 저자 정보
최근 본 자료
댓글(0)
0